Epithelial ovarian cancer: role of pegylated liposomal Doxorubicin in prolonging the platinum-free interval and cancer antigen 125 trends during treatment.

Tanguay, J S

Epithelial ovarian cancer: role of pegylated liposomal Doxorubicin in prolonging the platinum-free interval and cancer antigen 125 trends during treatment. [electronic resource] - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society Apr 2009 - 361-6 p. digital

Publication Type: Journal Article

1525-1438

10.1111/IGC.0b013e3181a1c7aa doi


CA-125 Antigen--metabolism
Carcinoma, Papillary--drug therapy
Cohort Studies
Cystadenocarcinoma, Serous--drug therapy
Doxorubicin--analogs & derivatives
Drug Resistance, Neoplasm
Endometrial Neoplasms--drug therapy
Female
Humans
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Neoplasm Staging
Ovarian Neoplasms--drug therapy
Platinum--therapeutic use
Polyethylene Glycols--therapeutic use
Prognosis
Retrospective Studies
Survival Rate
Treatment Outcome